Aminu Kano Teaching Hospital

Aminu Kano Teaching Hospital, a Nigerian teaching hospital, serves as a federal grant recipient under the National Institutes of Health (NIH) Fogarty International Center, conducting clinical HIV research and supporting research-capacity training programs. The institution operates as a prime grant recipient on one active award and as a sub-recipient on multiple NIH-funded research initiatives led by U.S. universities.

Aminu Kano Teaching Hospital is a corporate entity headquartered in Kano, Nigeria, with no federal contracts in its award footprint — all federal funding flows through competitive federal research grants. The institution functions predominantly as a sub-recipient (88% of recent awards), with only two prime awards since 2020, both federal grants rather than contracts. Its customer base concentrates entirely within the Department of Health and Human Services National Institutes of Health, with the Fogarty International Center accounting for 7 awards across the visible footprint and additional sub-awards routed through the National Human Genome Research Institute (3 awards), the National Institute of Child Health and Human Development (2 awards), and the National Institute of Neurological Disorders and Stroke (2 awards).

As a prime recipient, Aminu Kano Teaching Hospital holds a $232,347 Project Grant from FIC under the International Research and Research Training program (CFDA 93.989) awarded June 1, 2026 through May 31, 2028. The award funds clinical research investigating metabolic complications among persons with HIV in Nigeria, with focus on weight gain and metabolic dysfunction following integrase strand transfer inhibitor-based antiretroviral therapy. The research leverages Nigeria's standardized treatment environment and high HIV case volumes to conduct metabolic and lipid pathway analyses, participant recruitment and screening, and data collection — work that would be methodologically difficult to replicate in the United States due to the heterogeneity of approved antiretroviral medications and diverse treatment histories.

In its sub-recipient capacity, Aminu Kano Teaching Hospital participates in research-capacity building and training programs led by Vanderbilt University Medical Center and Johns Hopkins University, including the Vanderbilt-Nigeria Biostatistics Training Program (multiple awards since January 2023), the Vanderbilt-Nigeria Research Ethics Training Program (multiple awards since July 2024), the V-BRCH Vanderbilt-Nigeria Building Research Capacity in HIV and Non-communicable Diseases program (awarded January 20, 2025), and integrated biomarker-profiling research on metabolic syndrome in pregnant women living with HIV (Johns Hopkins, awarded March 30, 2026). Combined obligated dollars across all awards total $4.5 million, with activity accelerating markedly in 2025 and 2026 (seven awards in 2025, six in 2026 year-to-date) compared to prior years. One award faces ultimate completion within the next twenty-four months.